[1] | Cornell, J. A. (2002). Experiments with Mixtures: designs, models and the analysis of mixture data, 3rd Edition; New York:. John Wiley & Sons, Inc. |
[2] | Cornell, J. A. (2011). A primer on experiments with Mixtures. New Jersey: John Wiley & Sons, Inc. |
[3] | Scheffé, H. (1958). Experiments with Mixtures. Journal of the Royal Statistical Society, Series B, 20: 344-360. |
[4] | Scheffé, H. (1963). Simplex-Centroid designs for Experiments with Mixtures. Journal of the Royal Statistical Society, Series B, 25: 235-263. |
[5] | Cornell, J. A. (1990). Experiments with Mixtures: Designs, Models and the Analysis of Mixture Data, 2nd Edition. New York. John Wiley & Sons, Inc. |
[6] | Goos, P. & Bradley, J. (2011). Optimal Design of Experiments: A Case Study Approach. New York. John Wiley & Sons, Inc. |
[7] | Piepel, G. F. & Cooley, S. K. (2009). Automated method for reducing Scheffélinear mixture experiment odel. Quality Tech. & Quantitative Management, 6 (3): 255-270. |
[8] | Khuri, A. I. (2005). Slack variable models versus Scheffé’s mixture models. Journal of Applied Statistics; 32: 887-908. |
[9] | Piepel, G. F. (2007). A component slope linear model for mixture experiments. Quality Technology & Quantitative Management; 4(3): 331-343. |
[10] | Menon, S., Rajesh, G. & Balakrishnan, V. (2015). Pancreas and diabetes mellitus: the relationship between the organ and the disease. J of the Ass of Physicians of India, 63: 51-58. |
[11] | Redmon, B., Caccamo, D., Flavin, P., Michels, R. M. O’Connor, P., Roberts, J., Smith, S. & Sperl-Hillen, J. (2014). Diagnosis and Management of Type 2 Diabetes Mellitus in Adults. Institute for Clinical Systems Improvement; 6th Edition. |
[12] | Shakya, A., Chaudary, S. K., Garabadu, D., Bhat, H. R., Kakoti, B. B., Ghosh, S. K. (2020). A Comprehensive Review on Preclinical Diabetic Models. Curr Diabetes Rev; 16(2): 104-116. |
[13] | Gupta P. D. & Amartya, D. (2012). Diabetes Mellitus and its herbal treatment. International Journal of Research in Pharmaceutical and Biomedical Sciences, 3(2): 706-721. |
[14] | World Health Organization (2016). Global report on diabetes. Geneva, Switzerland. |
[15] | Chawla, A., Chawla, R., & Jaggi, S. (2016). Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian journal of endocrinology and metabolism, 20(4), 546–551. https://doi.org/10.4103/2230-8210.183480. |
[16] | Elnour, A. A (2018). The long‒term complications of hyperglycemia in both type1 and type 2 diabetic patients. MOJ Proteomics Bioinform; 7(5): 263‒264. |
[17] | Ghorbani, A., Varedi, M., Hadjzadeh, M. R. & Omrani, G. H. (2010). Type 1 diabetes and mass adipose tissues in the rat. Example Clinical Endocrinal Diabetes, 118:442-448. |
[18] | World Health Organization (2019). WHO global report on traditional and complementary medicine 2019: Geneva, Switzerland. Licence: CC BY-NC-SA 3.0 IGO. |
[19] | Mills, S. & Bone, K. (2000). Principles and practice of phytotherapy - modern herbal medicine. Churchill Livingstone, London, U.K. |
[20] | Sani, M. F., Kouhsari, S. M. & Moradabadi, L. (2012). Effects of three medicinal plants extracts in experimental diabetes: Antioxidant enzymes activities and plasma lipids profiles in comparison with Metformin. Iranian Journal of Pharmaceutical Research, 11(3): 897-903. |
[21] | Efiong, E. E., Igile, G. O., Mgbeje, B. I. A., Out, E. A. & Ebong P. E. (2013). Hepatoprotective and anti-diabetic effect of combined extracts of Moringaoleifera and Vernoniaamygdalina in STZ induced diabetic Albino Wistar rats. Journal of Diabetes and Endocrinology, 4(4): 45-50. |
[22] | Njoroge, G. G., Koske, J. A. & Simbauni, J. A. (2016). A Screening Experiment on a Diabetes Mellitus Herbal Formulation. American Journal of Theoretical and Applied Statistics; 5(6): 387-394. doi: 10.11648/j.ajtas.20160506.18. |
[23] | Risala, H. A., Raghdan, H. M. & Raghad, S. M. (2019). Study the effect of herbal mixture plants extract on blood sugarlevel in normal and experimentally diabetic mice. Bionatura; 4(4): 985-990. DOI: 10.21931/RB/2019.04.04.8. |
[24] | Ayala, J. E., Samuel, V. T., Morton, G. J., Obici, S., Croniger, C. M., Shulman, G. I., Wasserman, D. H., McGuinness, O. P., & NIH Mouse Metabolic Phenotyping Center Consortium (2010). Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Disease models & mechanisms, 3(9-10), 525–534. https://doi.org/10.1242/dmm.006239. |
[25] | American Diabetes Association, ADA. (2020). Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care; 43(Suppl 1): S14- S31. https://doi.org/10.2337/dc20-S002. |
[26] | Nair, A. & Jacob, S. (2016). A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy, 7(2): 27-31. |
[27] | Hosseini, A., Shorofi, S. S., Davoodi, A. & Azadhakht, M. (2018). Starting dose calculation for medicinal plants in animal studies; recommendation of a simple and reliable method. Research Journal of Pharmacognosy, 5(2): 1-7. |
[28] | Shin, J-W., Seol, I-C. & Son, C-G. (2010). Interpretation of animal dose and human equivalent dose for drug development. The Journal of Korean Oriental Medicine, 31(3): 1-7. |
[29] | Che, C. T., Wang, Z. J., Chow, M. S. S. & Lam, C. W. K. (2013). Herb-Herb combination for therapeutic enhancement and advancement: Theory, practice and future perspectives. Molecules; 18, 5125-5141. |